NBIX

Neurocrine Biosciences, Inc. Press Releases

$48.77
*  
0.70
1.46%
Get NBIX Alerts
*Delayed - data as of May 24, 2016  -  Find a broker to begin trading NBIX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NBIX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

Neurocrine Biosciences Announces the Retirement of W. Thomas Mitchell from the Board of Directors
5/20/2016 9:00:00 AM - PR Newswire
▲3.97 % Price Change since this news event. The Volume Ratio is 1.01.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
5/6/2016 3:00:00 PM - PR Newswire
▲14.35 % Price Change since this news event. The Volume Ratio is 1.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neurocrine Biosciences Announces Additional Valbenazine (NBI-98854) Data to be Presented at the American Psychiatric Association''s 2016 Annual Meeting in Atlanta
5/6/2016 8:30:00 AM - PR Newswire
▲9.47 % Price Change since this news event. The Volume Ratio is 1.52.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neurocrine Biosciences Reports First Quarter 2016 Results
5/5/2016 4:01:00 PM - PR Newswire
▲14.35 % Price Change since this news event. The Volume Ratio is 1.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2016 Results
4/29/2016 3:00:00 PM - PR Newswire
▲7.45 % Price Change since this news event. The Volume Ratio is 1.18.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neurocrine Biosciences to Present at the Deutsche Bank 41st Annual Health Care Conference
4/27/2016 3:00:00 PM - PR Newswire
▲5.72 % Price Change since this news event. The Volume Ratio is 1.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neurocrine Biosciences to Present at the Barclays Global Healthcare Conference
3/9/2016 1:00:00 PM - PR Newswire
▲45.71 % Price Change since this news event. The Volume Ratio is 0.84.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neurocrine Biosciences to Present at the Cowen and Company 36th Annual Health Care Conference
3/2/2016 6:30:00 PM - PR Newswire
▲26.68 % Price Change since this news event. The Volume Ratio is 1.45.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neurocrine Biosciences Announces the Acceptance of Three Scientific Abstracts for Valbenazine (NBI-98854) at the 68th Annual Meeting of the American Academy of Neurology in Vancouver April 2016
3/2/2016 8:30:00 AM - PR Newswire
▲30.12 % Price Change since this news event. The Volume Ratio is 1.32.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day